
The 98 gram pack of Himemaru Rice Crackers was sold in almost all states. Now the manufacturer is recalling the snack.
AI-generated summary
The product contains glycidyl fatty acid esters above the legal limit, which, according to the manufacturer, can have genotoxic and carcinogenic effects.
The trading company SSP consumer goods Trade & Consult GmbH is recalling the Himemaru Rice Crackers due to increased levels of a substance that is harmful to health. Products with a packaging unit of 98 grams are affected, with all valid best-before dates, as reported by the lebensmittelwarning.de portal.
The crackers would be sold in all federal states with the exception of Brandenburg and Mecklenburg-Western Pomerania.
According to information on the website of the company based in Dietzenbach, a laboratory test determined that the product contained glycidyl fatty acid esters above the legal limit. The substance could have a genotoxic and carcinogenic effect.

Due to the Ebola outbreak in the Democratic Republic of Congo, travelers to the USA must submit a health declaration from November 4th. Passengers must confirm that they have not stayed there in the last 21 days.

The German Red Cross warns of declining blood reserves due to the current wave of colds and the autumn holidays. The supply situation is tense in several federal states, which is why the DRK is calling on healthy people to make an appointment.

In the Democratic Republic of Congo, the number of Ebola cases has exceeded 10,000, with 4,887 people dead. The Africa CDC calls it the fastest outbreak in history. Cases have also been reported in Kenya and Nigeria.
In the dispute over the health savings package, statutory health insurance companies are accusing doctors of stirring up fears among insured people. Gassen, head of statutory health insurance physicians, had previously warned of longer waiting times.
In a clinical study, prime editing technology was used for the first time to correct a genetic mutation directly in the liver of a patient with Wilson's disease. The method promises more precise and less invasive gene therapy.

A 65-year-old woman died in Kenya as a result of an Ebola infection. She is the second death in the country and a relative of the first patient. According to the authorities, there is no evidence of a wider spread.